Effect of Trigonella foenum (fenugreek) vaginal cream on vaginal atrophy in postmenopausal women

被引:4
作者
Mazalzadeh, Fakhriyeh [1 ]
Hekmat, Khadijeh [2 ]
Namjouyan, Foroogh [3 ]
Saki, Amal [4 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Menopause Andropause Res Ctr, Dept Midwifery, Ahvaz, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Nursing & Midwifery Fac, Dept Midwifery, Ahvaz, Iran
[3] Ahvaz Jundishapur Univ Med Sci, Sch Pharm, Dept Pharm, Ahvaz, Iran
[4] Ahvaz Jundishapur Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Ahvaz, Iran
关键词
Fenugreek vaginal cream; menopause; vaginal atrophy; TOPICAL TREATMENT; DOUBLE-BLIND; ESTROGEN; EPITHELIUM; GEL;
D O I
10.4103/jfmpc.jfmpc_1220_19
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and Objective: Menopause forms one-third of women's lives. During this period, many women continue their sexual activities. One of the most prevalent postmenopausal complications is vaginal atrophy whose symptoms could have destructive effects on the life quality among postmenopausal women. Complications of using estrogen hormone to improve these symptoms are inevitable. One of the objectives of the present study is the assessment of the vaginal cream of Fenugreek on vaginal inflammation of atrophic vaginitis in postmenopausal women. Materials and Methods: For assessment of the effect of fenugreek vaginal cream among postmenopausal women who suffer from vaginal atrophy, the present study was carried out in the form of a double-blind clinical trial among sixty postmenopausal women, mainly who had been referred to Health Center 1 located in the east of Ahvaz in 2017. All participants of the present study who were diagnosed with vaginal atrophy were assigned into two groups of 30 randomly. One of these groups received placebo and the other one fenugreek 5% vaginal cream for a period of 8 weeks. Symptoms related to vaginal atrophy were investigated by means of a 4-degree scale (none, mild, moderate, and severe) and maturation vaginal index (MVI) through preparing the vaginal smears technique at baseline and a period of 8 weeks after cytology and intervention experiment. Finally, the process of analyzing statistical data, at a statistical significance level of 0.05, was carried out by means of SPSS Software. Results: The results of the present study demonstrated that the fenugreek vaginal cream treatment group experienced a significant improvement in vaginal atrophy symptoms compared to the onset of the study (P < 0.001). Conclusion: Fenugreek vaginal cream was effective in treating vaginal atrophy; therefore, postmenopausal women are recommended to use this cream instead of synthetic estrogen to reduce the complications of this hormone.
引用
收藏
页码:2714 / 2719
页数:6
相关论文
共 50 条
  • [41] Change in microbiota profile after vaginal estriol cream in postmenopausal women with stress incontinence
    Moore, Kate H.
    Ognenovska, Samantha
    Chua, Xin-Yi
    Chen, Zhuoran
    Hicks, Chloe
    El-Assaad, Fatima
    te West, Nevine
    El-Omar, Emad
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [42] Vaginal metabolites in postmenopausal women with or without vulvo-vaginal atrophy at baseline and after ospemifeme and systemic hormone treatment
    Foschi, Claudio
    Alvisi, Stefania
    Baldassarre, Maurizio
    Laghi, Luca
    Gava, Giulia
    Mancini, Ilaria
    Casadio, Paolo
    Seracchioli, Renato
    Meriggiola, Maria Cristina
    MATURITAS, 2022, 159 : 7 - 14
  • [43] Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy
    Simon, J. A.
    Maamari, R. V.
    CLIMACTERIC, 2013, 16 : 37 - 43
  • [44] EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy
    Rees, Margaret
    Perez-Lopez, Faustino R.
    Ceasu, Iuliana
    Depypere, Herman
    Erel, Tamer
    Lambrinoudaki, Irene
    Schenck-Gustafsson, Karin
    Simoncini, Tommaso
    van der Schouw, Yvonne
    Tremollieres, Florence
    MATURITAS, 2012, 73 (02) : 171 - 174
  • [45] Endometrial safety of ultra-low-dose Vagifem 10 μg in postmenopausal women with vaginal atrophy
    Ulrich, L. S. G.
    Naessen, T.
    Elia, D.
    Goldstein, J. A.
    Eugster-Hausmann, M.
    CLIMACTERIC, 2010, 13 (03) : 228 - 237
  • [46] Number of vaginal lactobacilli in postmenopausal women with vaginal atrophy before and after treatment with erbium-YAG laser: a randomized sham-controlled trial
    Panyawongudom, Nuttanun
    Panyakhamlerd, Krasean
    Suwan, Ammarin
    BMC WOMENS HEALTH, 2023, 23 (01)
  • [47] The effects of postmenopausal Vitamin D treatment on vaginal atrophy
    Yildirim, B
    Kaleli, B
    Düzcan, E
    Topuz, O
    MATURITAS, 2004, 49 (04) : 334 - 337
  • [48] A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom
    Archer, David F.
    Kimble, Thomas D.
    Lin, F. D. Yuhua
    Battucci, Simona
    Sniukiene, Vilma
    Liu, James H.
    JOURNAL OF WOMENS HEALTH, 2018, 27 (03) : 231 - 237
  • [49] A study of 17β-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy
    Cotreau, Monette M.
    Chennathukuzhi, Vargheese M.
    Harris, Heather A.
    Han, Lixin
    Dorner, Andrew J.
    Apseloff, Glen
    Varadarajan, Usha
    Hatstat, Ellyn
    Zakaria, Marjorie
    Strahs, Andrew L.
    Crabtree, Judy S.
    Winneker, Richard C.
    Jelinsky, Scott A.
    MATURITAS, 2007, 58 (04) : 366 - 376
  • [50] Prevalence and Impact of Vaginal Symptoms among Postmenopausal Women
    Santoro, Nanette
    Komi, Janne
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (08) : 2133 - 2142